Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | CTSS | P25774 | 7/20 | 0.38 |
| ▸ | CTSL | P07711 | 6/20 | 0.38 |
| ▸ | CTSB | P07858 | 3/20 | 0.37 |
| ▸ | CTSK | P43235 | 2/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6565489 | 0.86 | CTSS (0.47) | CTSSCTSLCTSBCTSKMCL1 | |
| SCHEMBL6565436 | 0.85 | CTSL (0.39) | L3MBTL1CTSSCTSLMAPT | |
| SCHEMBL6567353 | 0.77 | CHRNB2 (0.42) | L3MBTL1CTSSCTSLCTSBCTSK | |
| SCHEMBL6565446 | 0.73 | MCL1 (0.40) | L3MBTL1CTSSCTSLCTSBCTSK | |
| SCHEMBL7438096 | 0.72 | CTSS (0.42) | CTSSCTSLCTSBCTSK | |
| SCHEMBL6183160 | 0.71 | CTSS (0.49) | L3MBTL1CTSSCTSLCTSBCTSK | |
| SCHEMBL6563875 | 0.70 | CTSS (0.50) | CTSSCTSLCTSBCTSK | |
| SCHEMBL6237639 | 0.69 | ALDH1A1 (0.57) | L3MBTL1NPC1RAB9AMAPT | |
| SCHEMBL28603794 | 0.69 | MCL1 (0.51) | L3MBTL1MCL1NPC1RAB9AMAPT | |
| SCHEMBL28614724 | 0.69 | MCL1 (0.51) | L3MBTL1MCL1NPC1RAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002100849-A2 | NOVEL NITRILES USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2002-12-19 | — | — | WO | claimed |
| WO-2002100849-A2 | NOVEL NITRILES USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2002-12-19 | — | — | WO | disclosed |